Page 22 - Read Online
P. 22

Page 4 of 11                          Vong et al. J Cancer Metastasis Treat 2020;6:54  I  http://dx.doi.org/10.20517/2394-4722.2020.116















































               Figure 1. TTSH specialist outpatient clinic workflow for patients with respiratory symptoms after triage at hospital entrance. TTSH:
               Tan Tock Seng Hospital; MOH: Ministry of Health; NCID: The National Centre for Infectious Diseases; SASH: Swab-and-Send-Home;
               PHPC: Public Health Preparedness Clinic; SC: screening Centre; COVID-19: Coronavirus disease 2019; RT-PCR: reverse transcription-
               polymerase chain reaction; TKIs: tyrosine kinase inhibitors; SARS-CoV-2: severe acute respiratory syndrome virus 2

               Physicians’ non-essential leave was also cancelled in order to maximise existing manpower resources. The
               Singapore MOH also prohibited cross-hospital movement of physicians, thus necessitating clinic closures
               and redistribution of patients under the care of our visiting medical oncology consultants. Similarly, inter-
               hospital transfers of inpatients were discouraged unless there is a clinical need for specialised medical
               services not available at the parent hospital. Medical oncologists have also had to take up different duties in
               the management of the COVID-19 pandemic, with clinical redeployment to NCID on a regular rotational
               basis to provide acute care for confirmed and suspect COVID-19 patients as part of pandemic coverage in
               a broader hospital and national effort.

               COVID-19 SCREENING IN LUNG CANCER PATIENTS
               A recent meta-analysis has reported a pooled prevalence of cancer in patients with COVID-19 of 2.0%, an
                                                               [13]
               increased incidence compared to the general population . Multicentre registries and observational studies
               have demonstrated an association between increased COVID-19 mortality of 13%-28% in patients with
               cancer and COVID-19 [14,15] . Common independent factors include active cancer (as opposed to cancer in
               remission), underlying comorbidities such as COPD, smoking status, advanced age, and male gender [14,15] .
               Patients with Eastern Cooperative Oncology Group (ECOG) performance status of 2 or higher are at
                                                           [14]
               increased risk of worse outcomes from COVID-19 . One study has demonstrated lower rates of SARS-
   17   18   19   20   21   22   23   24   25   26   27